Abstract
At present it is not clear whether Alzheimer’s disease is a single disease, a complex syndrome, or a heterogeneous ill-defined group of disorders. In the last few years significant progress has been made in identifying and describing its different manifestations, as well as the underlying biological mechanisms. Modern molecular biology techniques have provided new insights into possible etiological mechanisms. Linkage analysis and gene sequencing studies have produced evidence of a possible locus on chromosome 21 in a small group of families with early onset familial Alzheimer’s disease (FAD). It was shown that another small group of early onset FAD families develops the disease as a result of mutations in the gene coding for the ß-amyloid precursor protein, and that in a larger subgroup of early onset families the disease appears to be caused by an unidentified gene on chromosome 14. Several other early onset FAD families are clearly not linked to any of these loci, suggesting that other abnormal genes, probably on different chromosomes, might be the cause of the disease in these families. Finally, it was recently shown that the ε4 allele of apolipoprotein E (ApoE) gene, which has been mapped to chromosome 19, is associated with an increased risk of developing the disease in late onset FAD families and sporadic cases. These results not only evidence that Alzheimer’s disease is a genetically heterogeneous disorder, but also delineate new approaches in the study of the etiological and pathogenetic mechanisms of Alzheimer’s disease. (Aging Clin. Exp. Res. 5: 417–425, 1993).
Similar content being viewed by others
References
Schottky J.: Uber prasenile Verblodungen. A. Gesamte. Neurol. Psychiatr. 140: 333–397, 1932.
Amaducci L., Forleo P., Piersanti P., Sorbi S. Clinical aspects of familial forms of Alzheimer’s disease. In: Mendlewicz J., Hippius H. (Eds.), Genetics Research in Psychiatry. Springer-Verlag, Berlin, 1992, pp. 75–87.
Amaducci L., Fratiglioni L., Rocca W.A., Fieschi C., Livrea P., Pedone D., Bracco L., Lippi A., Gandolfo C., Bino G.: Risk factors for clinically diagnosed Alzheimer’s disease: a case control study of an Italian population. Neurology 36: 922–931, 1986.
Graves A.B., White E., Koeosell T., Reifler B.V., van Belle G., Larson E.B., Raskin M.: A case-control study of Alzheimer’s disease. Ann. Neurol. 28: 140–148, 1990.
van Duijn C.M., Clayton D., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Jorm A.F., Kokmen E., Kondo K., Mortimer J.A., Rocca W.A., Shalat S.L., Soininen H., Hofman A.: Familial aggregation of Alzheimer’s disease and related disorders: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20: 13–20, 1991.
Breitner J.C.S., Silverman J.M., Mohs R.C., Davis K.L.: Familial aggregation in Alzheimer’s disease: comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations. Neurology 38: 207–212, 1988.
Jarvik L.F., Ruth V., Matsuyama S.S.: Organic brain syndrome and aging: a six year follow up of surviving twins. Arch. Gen. Psychiatry 37: 280–286, 1980.
Nee L.E., Eldridge R., Sunderland T., Thomas C.B., Katz D., Thompson K.E., Weingarten H.: Dementia of the Alzheimer’s type: clinical and family study of 22 twin pairs. Neurology 37: 359–363, 1987.
Cook R.H., Schneck S.A., Clark D.B.: Twins with Alzheimer’s disease. Arch. Neurol. 38: 300–301, 1981.
Peterson C., Gibson G.E., Blass J.P.: Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer’s disease. N. Engl. J. Med. 312: 1063–1065, 1985.
Robinson S.H., Munzer J.S., Tandan R., Bradley W.G.: Alzheimer’s disease cells exhibit defective repair of alkylating-induced DNA damage. Ann. Neurol. 21: 250–258, 1987.
Sims N.R., Finegan J.M., Blass J.P.: Altered metabolic properties of cultured skin fibroblasts in Alzheimer’s disease. Ann. Neurol. 21: 451–457, 1987.
Sheu K-F.R., Clarke D.D., Kim Y-T.: Studies of transketolase abnormalities in Alzheimer’s disease. Arch. Neurol. 45: 841–845, 1988.
Sorbi S., Blass J.P.: Fibroblasts phosphofructokinase in Alzheimer’s disease and Down’s syndrome. Banbury Rep. 15: 297–307, 1983.
Sorbi S., Mortilla M., Piacentini S., Tonini S., Amaducci L.: Altered hexokinase activity in skin cultured fibroblasts and leukocytes in Alzheimer’s disease patients. Neurosci. Lett. 112: 338–342, 1990.
Tesco G., Latorraca S., Piersanti P., Piacentini S., Amaducci L., Sorbi S.: Alzheimer skin fibroblasts show increased susceptibility to free radicals. Mech. Ageing Dev. 66: 117–120, 1992.
Tesco G., Vergelli M., Amaducci L., Sorbi S.: Growth properties of familial Alzheimer skin fibroblasts during in vitro aging. Exp. Gerontol. 28: 51–58, 1993.
Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C.: Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 235: 877–880, 1987.
Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St. George Hyslop P., Van Keuren M.L., Patterson D.: Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235: 880–884, 1987.
Robakis N.K., Ramakrishna N., Wolfe G., Wisniewski H.M.: Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci. USA 84: 4190–4194, 1987.
Kang J., Lemaire H.G., Unterback A., Salbaum J.M., Masters C.L., Grzeschil K.H., Multhaup G.: The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell surface receptor. Nature 325: 733–736, 1987.
St. George Hyslop P., Tanzi R.E., Polinsky R., Haines J., Nee L., Watkins P.C., Myers R., Feldman R., Pollen D., Drachmann D., Growdon J., Bruni A., Foncin J-F., Salmon D., Frommelt P., Amaducci L., Sorbi S., Piacentini S., Stuart G.D., Hobbs W.E., Conneally M.P., Gusella J.: The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235: 885–890, 1987.
Goate A.M., Haynes A.R., Owen M.J., Farral M., James L.A., Lai Y.A., Mullan M.J., Roques P., Rossor M.N., Williamson R., Hardy J.A.: Predisposing locus for Alzheimer’s disease is on chromosome 21. Lancet I: 352–355, 1989.
Van Broeckhoven C., Genthe A.M., Vandenberghe A., Horsthemke B., Backhovens J., Raeymaekers P., Van Hul W., Wehnert A., Gheuenst J., Cras P., Bruyland M., Martin J.J., Salbaum M., Multhaup G., Master C.L., Beyreuther K., Gurling H.M.D., Mullan M.J., Holland A., Barton A., Irving N., Williamson R., Richards S.J., Hardy J.A.: Failure of familial Alzheimer’s disease to segregate with the A4-amyloid gene in several European families. Nature 329: 153–155, 1987.
Schellenber G.D., Bird T.D., Wijsman E.M., Moore D.K., Boehnke M., Bryant E.M., Lampe T.H., Nochlin D., Sumi S.M., Deeb S.S., Beyreuther K., Martin G.M.: Absence of linkage of chromosome 21 marker 21q21 markers to familial Alzheimer’s disease. Science 241: 1507–1510, 1988.
Pericak-Vance M.A., Yamaoka L.H., Haynes C.S., Speer M.C., Gaskell P.C., Hung W.Y., Clark C.M., Heyman A.L., Gilbert J.R., Lee J.E., Alberts M.J., Earl N.L., Dawson D.V., Bartlett R.J., Siddique T., Vance J.M., Roses A.D., Trofatter J.A., Conneally P.M.: Linkage studies in Alzheimer’s disease families. In: Miner G.D. (Ed.), Familial Alzheimer’s Disease. Molecular Genetics and Clinical Perspectives. Marcel Dekker, Inc., New York, 1989, pp. 85–97.
Tanzi R.E., St. George Hyslop P.H., Haines J.L., Polinsky R.J., Nee L., Foncin J.F., Neve R.L., McClatchey A.I., Conneally P.M., Gusella J.F.: The genetic defect in familial Alzheimer’s disease is not tightly linked to the amyloid beta-protein gene. Nature 329: 156–157, 1987.
St. George Hyslop P.H., Haines J.L., Farrer L.A., Polinsky R., Van Broeckhoven C., Goate A., Crapper McLachlan D.R., Orr H., Bruni A.R., Sorbi S., Foncin J-F., Pollen D., Cantu J-M., Tupler R., Voskresenskaya N.I., Mayeux R., Frommelt P., Vatkins P.C., Gusella J.F., Hardy J.A., FAD Group: Genetic linkage studies suggest that Alzheimer’s disease is not a single homogeneous disorder. Nature 347: 194–197, 1990.
Schellenber G.D., Deeb S.S., Boehnke M.L.: Association of an apolipoprotein CII allele with familial dementia of the Alzheimer’s type. J. Neurogenet. 4: 97–108, 1987.
Perick-Vance M.A., Bebout J.L., Gaskell P.C., Yamaoka L.H.H., Alberts M.J., Walker A.P.: Linkage studies in familial Alzheimer’s disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 49: 1034–1050, 1991.
Schellenberg G.D., Boehnke M., Wijsman E.M., Moore D.K., Martin G.M., Bird T.M.: Genetic association and linkage analysis of the apolipoprotein CII locus and familial Alzheimer’s disease. Ann. Neurol. 31: 223–227, 1992.
Farrer L.A., Mayers R.H., Cupples L.A., St. George Hyslop P.H., Bird T.D., Rossor M.N., Mullan M.J., Polinsky R., Nee L., Heston L., Van Broeckoven C., Martin J.J., Crapper McLachlan D., Growdon J.H.: Transmission and age at onset patterns in familial Alzheimer’s disease: evidence for heterogeneity. Neurology 40: 395–403, 1990.
Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Perick-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J.: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706, 1991.
Fidani L.: Screening for mutations in the open reading frame and promoter of the ß-amyloid precursor protein gene in Familial Alzheimer’s disease: identification of a further family with APP Val—>Ile. Hum. Mol. Genet. 1: 165–168, 1992.
Karlinsky H., Vaula G., Haines J.L., Ridgley J., Bergeron C., Mortilla M., Tupler R.G., Percy M.E., Robitaille Y., Noldy N.E., Yip T.C.K., Tanzi R.E., Gusella J.F., Becker R., Berg J.M., Crapper McLachan D.R., St. George Hyslop P.H.: Molecular and prospective phenotypic characterization of a pedigree with Familial Alzheimer’s disease and a missense mutation in codon 717 of the ß-amyloid precursor protein gene. Neurology 42: 1445–1453, 1992.
Murrell J., Farlow M., Ghetti B., Benson M.: A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254: 97–99, 1991.
Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M.: Early onset Alzheimer’s disease caused by mutations of codon 717 of the ß-amyloid precursor protein gene. Nature 353: 844–846, 1991.
Chartier-Harlin M.C., Crawford F., Hamandi K., Mullan M., Goate A.: Screening for the ß-amyloid precursor mutation (APP Val—>Ile) in extended pedigrees with early onset Alzheimer’s disease. Neurosci. Lett. 129: 134–135, 1991.
Naruse S., Igarashi S., Aoki K., Kaneko K., Iihara K., Miyatake T., Kobayashi H., Inuzuka T., Shimizu T., Kojima T., Tsuji S.: Mis-sense mutation Val—>Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer’s disease. Lancet 337: 978–979, 1991.
Yoshioka K., Miki T., Katsuya T., Ogihara T., Sakaki Y.: The 717 Val—>Ile substitution in amyloid precursor protein is associated with familial Alzheimer’s disease regardless of ethnic group. Biochem. Biophys. Res. Commun. 178: 1141–1146, 1991.
Sorbi S., Nacmias P., Forleo P., Piacentini S., Amaducci L., Provinciali L.: APP717 and Alzheimer’s disease in Italy. Nature Genet. 4: 10, 1993.
Murrell J., Falrow M., Ghetti B., Benson M.: A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254: 97–99, 1991.
Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L.: A pathogenetic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of ß-amyloid. Nature Genet. 1: 345–346, 1992.
Hardy J., Chartier-Harlin M.C., Mullan M.: Alzheimer disease: The new agenda. Am. J. Hum. Genet. 50: 648–651, 1992.
Hardy J., Houlden H., Collinge J., Kennedy A., Newman S., Rossor M., Lannfelt L., Lilius L., Winblad B., Crook R., Duff K.: Apolipoprotein E genotype and Alzheimer’s disease. Lancet 342: 737–738, 1993.
Weitkamp L.R., Nee L., Keats B., Polinsky R.J., Guttoemson S.: Alzheimer’s disease: Evidence for susceptibility loci on chromosome 6 and 14. Am. J. Hum. Genet. 37: 482–498, 1983.
St. George Hyslop P.H., Haines J., Myers R., Polinsky R., Nee L., Bruni A., Sorbi S., Piacentini S., Amaducci L., Fonscin J-F., Feldman R.G., Frommelt P., Watkins P., Tanzi R., Aalbo J., Growdon J., Drachman D., Pollen D., Conneally P.M., Gusella J.: Familial and sporadic Alzheimer’s disease: Molecular Genetic Approaches. In: Blass J.P., et al. (Eds.), Familial Alzheimer’s Diseases: Molecular Genetics and Clinical Perspectives. Marcel Dekker, New York, U.S.A., 1989, pp. 99–102.
St. George Hyslop P.H., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J-F., Montesi M., Sorbi S., Rainero I., Pinessi L., Pollen D., Polinsky R., Nee L., Kennedy J., Macciardi F., Rogaeva E., Liang Y., Alexandrova N., Lukiw W., Schlumpf K., Tanzi R., Tsuda T., Farrer L., Cantu J-M., Duara R., Amaducci L., Bergamini L., Gusella J., Roses A., Crapper McLachlan D.: Genetic evidence for a novel Familial Alzheimer’s disease locus on chromosome 14. Nature Genet. 2: 330–339, 1992.
Schellenberg G.D., Bird T.D., Wijsman E.M., Orr H.T., Anderson L., Nemens E., White J.A., Bonnycastle L., Weber J.L., Alonso M.E., Potter H., Heston L.L., Martin G.M.: Genetic linkage evidence for a Familial Alzheimer’s disease locus on chromosome 14. Science 258: 668–671, 1992.
Van Broeckhoven C., Backhovens H., Cruts M., De Winter G., Bruyland M., Cras P., Martin J.J.: Mapping of a gene predisposing to early-onset Alzheimer’s disease to chromosome 14q24.3. Nature Genet 2: 335–339, 1992.
Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A.: Gene dosage of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261: 921–923, 1993.
Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D.: Apolipoprotein E: High-avidity binding to ß-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 90: 1977–1981, 1993.
Saunders A.M., Schmader K., Breitner J.C.S., Benson M.D., Brown W.T., Goldfarb L., Goldgaber D., Manwaring M.G., Szymanski M.H., McCown N., Dole K.C., Schmechel D.E., Strittmatter W.J., Pericak-Vance M.A., Roses A.D.: Apolipoprotein E ε4 allele distribution in late-onset Alzheimer’s disease and in other amyloid forming diseases. Lancet 342: 710–712, 1993.
Noguchi S., Murakami K., Yamada N.: Apolipoprotein E and Alzheimer’s disease. Lancet 342: 737, 1993.
Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S.: Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet 342: 697–699, 1993.
Saunders A.M., Strittmatter W.J., Schmechel D., St. George Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper McLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D.: Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer’s disease. Neurology 43: 1467–1472, 1993.
Scott J.: Apolipoprotein E and Alzheimer’s disease. Lancet 342: 696, 1993.
Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M.A., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D.: Binding of human apolipoprotein E to synthetic amyloid ß peptide: isoform specific effects and implications for late onset Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 90: 8098–8102, 1993.
Paik Y-K., Chang D.J., Reardon C.A., Davies G.E., Mahley R.W., Taylor J.M.: Nucleotide sequence and structure of the human apolipoprotein E gene. Proc. Natl. Acad. Sci. USA 82: 3445–3449, 1985.
Poirier J., Hess M., May P.C., Finch C.E.: Apolipoprotein E and GFAP-RNA in hippocampus during reactive synaptogenesis and terminal proliferation. Mol. Brain Res: 11: 97–106, 1991.
Gerdes L.U., Klausen I.C., Sihm I., Faergeman O.: Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet. Epidemiol. 9: 155–167, 1992.
Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K.: Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease. Brain Res. 541:163–166, 1991.
Mucjkle T.J., Roy J.R.: High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet I: 1191–1192, 1985.
Mahley R.W.: Apolipoprotein E: cholesterol transport protein expanding role in cell biology (Review). Science 240: 622–630, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sorbi, S. Molecular genetics of Alzheimer’s disease. Aging Clin Exp Res 5, 417–425 (1993). https://doi.org/10.1007/BF03324196
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324196